Tu1771 Impedance-pH Explores With More Accuracy Than pH-Metry Alone the Relationship Between Aspiration of Gastric Contents and Gastroesophageal Reflux in Patients With Idiopathic Pulmonary Fibrosis

2013 ◽  
Vol 144 (5) ◽  
pp. S-840-S-841
Author(s):  
Edoardo Savarino ◽  
Patrizia Zentilin ◽  
Elisa Marabotto ◽  
Manuele Furnari ◽  
Luca Bruzzone ◽  
...  
2012 ◽  
Vol 142 (5) ◽  
pp. S-100-S-101
Author(s):  
Edoardo Savarino ◽  
Patrizia Zentilin ◽  
Manuele Furnari ◽  
Luca M. Sconfienza ◽  
Vincenzo Savarino

2017 ◽  
Vol 95 (5) ◽  
pp. 389-393
Author(s):  
V. A. Akhmedov ◽  
O. V. Gaus ◽  
D. V. Petrov

Idiopathic pulmonary fibrosis (IPF) is a most widespread clinic-morphological variant of Idiopathic interstitial pneumonias. Its pathophysiology includes recurrent damages to epithelial cells and anomalous reparative reaction in response to aseptic inflammation in the form of excess fibroblast proliferation. The cause of epithelium damage remains unknown; the involvement of smoking, viral infections, inhaled pollutants, and toxic drug n the initiation of the pathological process is conjectured. Numerous studies of recent years suggest the potential role of gastroesophageal reflux and microaspiration as etiological factors of IPF progression. A brief review of modern views of the relationship between IPF and gastroesophageal reflux is presented.


2012 ◽  
Vol 44 ◽  
pp. S148
Author(s):  
E. Savarino ◽  
P. Zentilin ◽  
E. Marabotto ◽  
M. Furnari ◽  
L. Bruzzone ◽  
...  

2020 ◽  
Vol 59 (1) ◽  
Author(s):  
Filippo Patrucco ◽  
Ludovica Venezia ◽  
Roberta Nicali ◽  
Rinaldo Pellicano ◽  
Mattia Bellan ◽  
...  

2021 ◽  
Vol 10 (7) ◽  
pp. 1427
Author(s):  
Steven D. Nathan ◽  
Jayesh Mehta ◽  
John Stauffer ◽  
Elizabeth Morgenthien ◽  
Ming Yang ◽  
...  

Identification of prognostic and predictive biomarkers in idiopathic pulmonary fibrosis (IPF) could aid assessment of disease severity and prediction of progression and response to treatment. This analysis examined reference ranges for neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR) in IPF, and the relationship between NLR or PLR changes and clinical outcomes over 12 months. This post hoc analysis included patients with IPF from the Phase III, double-blind trials of pirfenidone, ASCEND (NCT01366209) and CAPACITY (NCT00287716 and NCT00287729). The relationship between change from baseline to Month 12 in NLR or PLR (divided into quartiles (Q1–Q4)) and outcomes (mortality, respiratory hospitalization, declines in lung function, exercise capacity and quality of life) was assessed. Estimated reference ranges at baseline for all patients analyzed (n = 1334) were 1.1–6.4 for NLR and 56.8–250.5 for PLR. Significant trends were observed across NLR and PLR quartiles for all outcomes in placebo-treated patients, with patients manifesting the greatest NLR or PLR changes experiencing the worst outcomes. These results suggest that the greatest NLR or PLR changes over 12 months were associated with worse clinical outcomes. Further research is needed to determine the utility of NLR and PLR as prognostic biomarkers in IPF.


Medicina ◽  
2011 ◽  
Vol 47 (4) ◽  
pp. 28 ◽  
Author(s):  
Ahmed Fahim ◽  
Peter Dettmar ◽  
Alyn Morice ◽  
Simon Hart

Background and Objective. Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial pneumonias. There is evidence of the increased prevalence of gastroesophageal reflux disease in patients with IPF. The aim of this prospective study was to evaluate reflux in patients with IPF by analyzing the scores of the reflux cough questionnaire, measurement of pepsin in exhaled breath condensate (EBC) to detect extraesophageal reflux, and Helicobacter pylori serology to evaluate the prevalence of this stomach bacterium in patients with IPF. Material and Methods. The Hull airway reflux questionnaire (HARQ) was completed by 40 patients with IPF and 50 controls in order to evaluate reflux symptoms. EBC was collected from 23 patients (17 patients with IPF and 6 controls) for measurement of pepsin by the lateral flow technique. A prospective study of 57 subjects (34 patients with IPF and 23 controls) for H. pylori antibody detection by ELISA was performed. Results. Significantly higher HARQ scores (maximum score, 70) were recorded in patients with IPF compared with controls (19.6 [SD, 12.4] vs. 3 [SD, 2.9], P<0.001). There was no significant difference in EBC pepsin positivity between patients with IPF and controls (2 of the 17 patients vs. none of the 6 controls, P=0.38). There was no significant difference in H. pylori serology between patients with IPF and controls (17 of the 34 patients vs. 14 of the 23 controls, P=0.42). Conclusion. Patients with IPF had significantly increased scores of airway reflux symptoms. However, no objective evidence of extraesophageal reflux or H. pylori infection in patients with IPF was obtained in this study. The role of gastroesophageal and extraesophageal reflux in pathogenesis of IPF should be evaluated in a larger prospective study.


Respiration ◽  
2018 ◽  
Vol 96 (6) ◽  
pp. 571-587 ◽  
Author(s):  
Zheng Wang ◽  
Francesco Bonella ◽  
Wenting Li ◽  
Eda B. Boerner ◽  
Qiongya Guo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document